{{Rsnum
|rsid=6127984
|Gene=BMP7
|Chromosome=20
|position=57249537
|Orientation=plus
|GMAF=0.3535
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BMP7
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 58.4 | 34.5
| HCB | 5.8 | 30.7 | 63.5
| JPT | 7.1 | 35.4 | 57.5
| YRI | 21.1 | 54.4 | 24.5
| ASW | 16.1 | 57.1 | 26.8
| CHB | 5.8 | 30.7 | 63.5
| CHD | 9.2 | 28.4 | 62.4
| GIH | 13.9 | 46.5 | 39.6
| LWK | 10.1 | 41.3 | 48.6
| MEX | 20.7 | 48.3 | 31.0
| MKK | 12.2 | 53.2 | 34.6
| TSI | 9.8 | 51.0 | 39.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs6127984
|Name_s=
|Gene_s=BMP7
|Feature=
|Evidence=PubMed ID:17537913
|Annotation=Risk or phenotype-associated allele: not stated Phenotype: Using a Quantitative Transmission Disequilibrium Test (QTDT), this variant was significantly associated with etoposide toxicity based upon IC50 values in cell lines from 30 parent-child trios. Study size: 87. Study population/ethnicity: 87 European descent Caucasians. Significance metric(s): p = 0.00004. Type of association: FA; GN.
|Drugs=etoposide
|Drug Classes=
|Diseases=Drug Toxicity
|Curation Level=Curated
|PharmGKB Accession ID=PA165109330
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6127984
|overall_frequency_n=45
|overall_frequency_d=120
|overall_frequency=0.375
|n_genomes=32
|n_genomes_annotated=0
|n_haplomes=37
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}